Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aligos Therapeutics Inc. logo

Aligos Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

Optionable: Yes  Market Cap: 41 M  90-day average vol: 411,437

Previous close: 0.493  Open: 0.49  Bid: 0.51  Ask: 0.531
52 week range    
Last updated: Sunday 21st July 2024
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ALGS Income Statement

Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-10.87-3.22-2.25-1.36
Basic EPS total-10.87-3.22-2.25-1.36
Basic weighted shares outstanding10 M40 M43 M64 M
Depreciation3 M3 M2 M2 M
DepreciationAndAmortization3 M3 M2 M2 M
Diluted EPS total-10.87-3.22-2.25-1.36
Diluted normalized net income/share-1.36
Diluted weighted shares outstanding10 M40 M64 M
GeneralAndAdministrativeExpense18 M29 M26 M31 M
Gross operating profit6 M
Income before tax-108 M-128 M-96 M-87 M
Income taxes161000.0143000.0106000.0795000.0
InterestExpenseNonOperating9000.015000.0-1 M-4 M
MiscOtherSpecialCharges-757000.04 M14 M9 M
Net income from total operations-109 M-128 M-96 M-88 M
NetIncomeCommonStockholders-109 M-128 M-96 M-88 M
NetIncomeContinuousOperations-109 M-128 M-96 M-88 M
NetNonOperatingInterestIncomeExpense-9000.0-15000.02 M4 M
Normalized income-69 M
Operating income-98 M-128 M-98 M-88 M
Operating income before depreciation (EBITDA)-95 M-125 M-94 M-85 M
OperatingExpense98 M133 M111 M104 M
Other income net-68000.0-4 M-14 M-9 M
OtherGandA18 M29 M26 M31 M
OtherOperatingExpenses11 M-132000.0-2 M-1 M
Research & development expense80 M104 M85 M73 M
ResearchExpense80 M104 M85 M73 M
Selling Gen & administrative expense18 M29 M26 M31 M
Total Income available for interest expense (EBIT)-98 M-128 M-98 M-88 M
Total common shares outstanding38 M43 M43 M76 M
Total net income-109 M-128 M-96 M-88 M
Total ordinary shares75 M75 M75 M75 M
Total revenues6 M
TotalExpenses98 M133 M111 M104 M
TotalRevenue16 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University